116 related articles for article (PubMed ID: 15552801)
1. Molecular oncology--perspectives in lung cancer.
Huber RM; Stratakis DF
Lung Cancer; 2004 Aug; 45 Suppl 2():S209-13. PubMed ID: 15552801
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targets.
Motadi LR; Misso NL; Dlamini Z; Bhoola KD
Int Immunopharmacol; 2007 Dec; 7(14):1934-47. PubMed ID: 18039530
[TBL] [Abstract][Full Text] [Related]
3. Targeting angiogenesis in lung cancer.
Sandler AB
Semin Oncol; 2005 Dec; 32(6 Suppl 10):S16-22. PubMed ID: 16459175
[TBL] [Abstract][Full Text] [Related]
4. New targets for non-small-cell lung cancer therapy.
Alvarez M; Roman E; Santos ES; Raez LE
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1423-37. PubMed ID: 17944567
[TBL] [Abstract][Full Text] [Related]
5. [Molecular therapy targets in lung cancer].
Le Guen Y; Sabatier L; Le Chevalier T; Soria JC
Bull Cancer; 2003 Dec; 90(12):1055-61. PubMed ID: 14715425
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.
Bremnes RM; Camps C; Sirera R
Lung Cancer; 2006 Feb; 51(2):143-58. PubMed ID: 16360975
[TBL] [Abstract][Full Text] [Related]
7. Signal transduction pathways as novel therapy targets in lung cancer.
Reinmuth N; Mesters RM; Bieker R; Hoffknecht P; Berdel WE; Thomas M
Lung Cancer; 2004 Aug; 45 Suppl 2():S177-86. PubMed ID: 15552798
[TBL] [Abstract][Full Text] [Related]
8. [Lung cancer].
Haugen A
Tidsskr Nor Laegeforen; 1998 Jun; 118(15):2362-5. PubMed ID: 9691805
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.
Dacic S
Expert Rev Mol Diagn; 2007 Jan; 7(1):77-86. PubMed ID: 17187486
[TBL] [Abstract][Full Text] [Related]
10. [Developments in cancer care with innovative genomics. 2008 report of the National Cancer Consortium].
Tímár J; Kásler M; Heringh A; Soós M; Mathiász D; Romány A; Józsa A; Szilák L; Forrai T; Patthy L; Kovács G
Magy Onkol; 2009 Dec; 53(4):321-34. PubMed ID: 20071304
[TBL] [Abstract][Full Text] [Related]
11. The molecular biology of lung cancer: application to early detection and prevention.
Sabichi AL; Birrer MJ
Oncology (Williston Park); 1993 Jun; 7(6):19-26; discussion 31-2, 37. PubMed ID: 8318356
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review.
Singhal S; Vachani A; Antin-Ozerkis D; Kaiser LR; Albelda SM
Clin Cancer Res; 2005 Jun; 11(11):3974-86. PubMed ID: 15930332
[TBL] [Abstract][Full Text] [Related]
13. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy for lung cancer.
Toloza EM; Morse MA; Lyerly HK
J Cell Biochem; 2006 Sep; 99(1):1-22. PubMed ID: 16767697
[TBL] [Abstract][Full Text] [Related]
15. Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways.
Wallerand H; Reiter RR; Ravaud A
Curr Opin Urol; 2008 Sep; 18(5):524-32. PubMed ID: 18670279
[TBL] [Abstract][Full Text] [Related]
16. Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program.
Baryshnikova E; Destro A; Infante MV; Cavuto S; Cariboni U; Alloisio M; Ceresoli GL; Lutman R; Brambilla G; Chiesa G; Ravasi G; Roncalli M
Clin Cancer Res; 2008 Mar; 14(6):1913-9. PubMed ID: 18347195
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
Bremnes RM; Sirera R; Camps C
Lung Cancer; 2005 Jul; 49(1):1-12. PubMed ID: 15949585
[TBL] [Abstract][Full Text] [Related]
18. Multitargeted inhibitors in lung cancer: new clinical data.
Bar J; Herbst RS; Onn A
Clin Lung Cancer; 2008; 9 Suppl 3():S92-9. PubMed ID: 19419930
[TBL] [Abstract][Full Text] [Related]
19. The emerging role of vascular endothelial growth factor receptor tyrosine kinase inhibitors.
Langer CJ; Natale RB
Semin Oncol; 2005 Dec; 32(6 Suppl 10):S23-9. PubMed ID: 16459176
[TBL] [Abstract][Full Text] [Related]
20. [Angiogenesis and lung cancer].
Pérol M; Arpin D
Bull Cancer; 2007 Jul; 94 Spec No():S220-31. PubMed ID: 17846008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
